Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for September 2005
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Lilly increasing investment in UK R&D
New £26 million UK research facility opened..(more)

 NICE to review guidance on hypertension treatments
ASCOT trial opens up new treatment possibilities..(more)

 US rejects Pfizer's injectable Cox-II
Further blow after Bextra withdrawal..(more)

 Novartis pipeline promises cardiovascular advances
Novartis hoping to expand cardiovascular presence ..(more)

 Once a month osteoporosis pill launched
Roche and GSK launch Bonviva..(more)

 Roche's Tarceva approved in Europe
Tarceva to take lung cancer treatment a step forward..(more)

 New data gives Seretide upper hand in respiratory battle
Fixed dose Seretide achieves excellent asthma control..(more)

 Biotechs back change to UK pricing system
BIA raises concerns ahead of PPRS review..(more)

 National healthcare debate launched
'Your Say' initiative to run for eight weeks..(more)

 New NHS leaders in Alzheimer's research and development
Government focuses on six key therapy areas..(more)

 Postcode prescribing down to poor financial management, says report
Trusts disagree with Audit Commission conclusions..(more)

 Exubera receives FDA vote of confidence
Inhaled insulin treatment could net co-developers $2 billion..(more)

 GSK acquires vaccines research and manufacturing facility
GSK looks to strengthen vaccines business..(more)

 Industry braced for new upheaval in primary care
Practice-based commissioning main driver of change..(more)

 Pfizer to select seven for preferred supplier list
Pfizer draws up 'preferred list' of healthcare agencies..(more)

 Pfizer and Sanofi battle challenges on patents
Implications could be huge for industry and NHS..(more)

 A far stricter code - but more scope for communication too
Industry critic rues wasted opportunity..(more)

 Merck's problems deepen as MHRA reveals investigation
MHRA discloses investigation into possible withheld Vioxx data ..(more)

 New RA drug from BMS gains recommendation
Orencia step closer to approval for RA..(more)

 GP contract hailed as great success
But PCTs must foot bill..(more)

 New NHS early warning system for long-term conditions
Computer program to warn clinicians..(more)

 All new product marketing to be pre-vetted in UK
Government responds to Health Select Committee inquiry..(more)

 NHS spending on cancer drugs increasing
Criticism from Roche and charities results in action..(more)

 Takeda's dependence-free sleeping pill approved
Competition increasing in market..(more)

 Schering's new low-dose contraceptive approved in Netherlands
Schering extends product portfolio with Yasminelle..(more)

 Scientists back testing after guinea pig breeder forced to close
Activists turn attention to Huntingdon Life Sciences ..(more)

 Junior doctors to be taught communication skills
Foundation training programme launched..(more)

 Pfizer demands action after more fake Lipitor found in UK
Pfizer recalls 120,000 packs of Lipitor..(more)

 MHRA considers POM to P migraine drug switch
CSM to advise on switch in early October..(more)

 $1 billion Cialis closing on Viagra
Cialis leads the way in France..(more)

 Mixed news for Lilly's neuropathy drug
Sales forecast for Arxxant downgraded..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.